Join us at RESI (REDIFINING EARLY-STAGE INVESTMENTS) event in Boston, MA, USA from September 22nd to 23rd and meet our Managing Director, Stijn Otte. Sillar Clinical has a proven track record of guiding and supporting SME Medtech and Biotech companies as well as academic institutions. We specialize in the setup and conduct of your clinical trials, as well as helping you smoothly transition from pre-clinical to clinical.
About RESI event:
RESI Boston is a leading investor-focused partnering conference for early-stage life science and healthcare innovation. A key component of Biotech Week Boston, it connects fundraising companies, from Seed to Series B, with investors, corporate business development and licensing executives, and strategic service providers.
Whether you are a biotech, MedTech, diagnostics or digital health entrepreneur; an investor or licensing professional; or a CRO, CDMO, consultant or other industry partner, RESI Boston offers a highly targeted environment to arrange one-to-one meetings, present innovative projects and build valuable relationships across the global life sciences ecosystem.
For more information about the event, click here
You can book your meeting with Sillar Clinical's team through the contact page of our website and through the event's platform.
We are looking forward to meeting you during RESI Boston!